Tetrahydrouridine
 
		Product Description
CAT No.
				
									ALN-C003014								
				CAS No.
				
									18771-50-1								
				Mol. F.
				
									C9H16N2O6								
				Mol. Wt.
				
									248.2								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : Tetrahydro-4-hydroxy-1-β-D-ribofuranosyl-2(1H)-pyrimidinone								
				
									Smiles : OC(CCN1[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)NC1=O								
				
									Inchi : InChI=1S/C13H16FN3O7/c1-5(19)22-9-8(4-18)24-12(10(9)23-6(2)20)17-3-7(14)11(15)16-13(17)21/h3,8-10,12,18H,4H2,1-2H3,(H2,15,16,21)/t8-,9-,10-,12+/m1/s1								
				
									Synonym : 3,4,5,6-Tetrahydrouridine								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry
									By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, ShaileshnFrom American Journal of PharmTech Research (2020), 10(6), 115-133								
				Validated stability indicating HPLC method for estimation of capecitabine
									By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N. – From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658 								
				RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)
									By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K. – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            